These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9432192)

  • 1. [The diffusion and dissolution of metronidazole and doxepin in semisolid pharmaceutical forms through synthetic membranes].
    Széliga ME; Lamas MC; Lillo DA; Bregni C
    Boll Chim Farm; 1997; 136(7):527-32. PubMed ID: 9432192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
    Gido C; Langguth P; Kreuter J; Winter G; Woog H; Mutschler E
    Pharmazie; 1993 Oct; 48(10):764-9. PubMed ID: 8265710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose doxepin (Silenor) for insomnia.
    Med Lett Drugs Ther; 2010 Oct; 52(1348):79-80. PubMed ID: 20885342
    [No Abstract]   [Full Text] [Related]  

  • 4. Low-dose doxepin for the treatment of insomnia: emerging data.
    Goforth HW
    Expert Opin Pharmacother; 2009 Jul; 10(10):1649-55. PubMed ID: 19496739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute bioavailability and stereoselective pharmacokinetics of doxepin.
    Yan JH; Hubbard JW; McKay G; Korchinski ED; Midha KK
    Xenobiotica; 2002 Jul; 32(7):615-23. PubMed ID: 12162857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of the pharmaceutical metronidazole via UV, Fenton and photo-Fenton processes.
    Shemer H; Kunukcu YK; Linden KG
    Chemosphere; 2006 Apr; 63(2):269-76. PubMed ID: 16154173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of entrapment of metronidazole in amphiphilic beta-cyclodextrin nanospheres.
    Lahiani-Skiba M; Bounoure F; Shawky-Tous S; Arnaud P; Skiba M
    J Pharm Biomed Anal; 2006 Jun; 41(3):1017-21. PubMed ID: 16497467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, development and characterization of buccal bioadhesive films of Doxepin for treatment of odontalgia.
    Castán H; Ruiz MA; Clares B; Morales ME
    Drug Deliv; 2015; 22(6):869-76. PubMed ID: 24670096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro dissolution kinetic study of theophylline from hydrophilic and hydrophobic matrices.
    Maswadeh HM; Semreen MH; Abdulhalim AA
    Acta Pol Pharm; 2006; 63(1):63-7. PubMed ID: 17515331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEG-metronidazole conjugates: synthesis, in vitro and in vivo properties.
    Bersani C; Berna M; Pasut G; Veronese FM
    Farmaco; 2005 Sep; 60(9):783-8. PubMed ID: 16040031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extractive spectrophotometric methods for the determination of doxepin hydrochloride in pharmaceutical preparations using titanium (IV) and iron (III) thiocyanate complexes.
    Misiuk W
    Farmaco; 2005 Jan; 60(1):61-9. PubMed ID: 15652371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pain in cancer patients with oral mucositis: follow-up of multiple doses of doxepin oral rinse.
    Epstein JB; Epstein JD; Epstein MS; Oien H; Truelove EL
    J Pain Symptom Manage; 2007 Feb; 33(2):111-4. PubMed ID: 17280915
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcutaneous electroporation mediated delivery of doxepin-HPCD complex: a sustained release approach for treatment of postherpetic neuralgia.
    Sammeta SM; Vaka SR; Murthy SN
    J Control Release; 2010 Mar; 142(3):361-7. PubMed ID: 19922748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the interaction between doxepin hydrochloride and bovine serum albumin by spectroscopic techniques.
    Kandagal PB; Seetharamappa J; Ashoka S; Shaikh SM; Manjunatha DH
    Int J Biol Macromol; 2006 Nov; 39(4-5):234-9. PubMed ID: 16678251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral doxepin rinse: the analgesic effect and duration of pain reduction in patients with oral mucositis due to cancer therapy.
    Epstein JB; Epstein JD; Epstein MS; Oien H; Truelove EL
    Anesth Analg; 2006 Aug; 103(2):465-70, table of contents. PubMed ID: 16861436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose escalation of doxepin for intractable pruritus.
    Beck KM; Yang EJ; Koo J
    J Am Acad Dermatol; 2018 Sep; 79(3):e37. PubMed ID: 30119870
    [No Abstract]   [Full Text] [Related]  

  • 17. In-vitro evaluation and vaginal absorption of metronidazole suppositories in rabbits.
    Ozyazici M; Turgut EH; Taner MS; Köseoglu K; Ertan G
    J Drug Target; 2003 Apr; 11(3):177-85. PubMed ID: 14577974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a buccal doxepin platform for pain in oral mucositis derived from head and neck cancer treatment.
    Sanz R; Calpena AC; Mallandrich M; Gimeno Á; Halbaut L; Clares B
    Eur J Pharm Biopharm; 2017 Aug; 117():203-211. PubMed ID: 28438551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential penetration of skin by topical metronidazole formulations.
    Wagner N; Berthaud C; Laffet G; Caron JC
    Adv Ther; 1998; 15(4):197-205. PubMed ID: 10186942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiamoebic activity of metronidazole thiosemicarbazone analogues.
    Abid M; Agarwal SM; Azam A
    Eur J Med Chem; 2008 Sep; 43(9):2035-9. PubMed ID: 18242785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.